Iscovich J, Boffetta P, Winkelmann R, Brennan P, Azizi E
Israel Cancer Registry, Ministry of Health, Jerusalem.
AIDS. 1998 Oct 22;12(15):2067-72. doi: 10.1097/00002030-199815000-00019.
The incidence of classic Kaposi's sarcoma (CKS) has been reported to be high in Jewish populations, mostly born in Eastern Europe.
To describe the incidence on CKS in Israeli Jews and to determine differences in incidence according to their geography origin.
We analysed data on 1098 incident CKS cases with known country of origin occurring between 1961 and 1989 in the Jewish Israeli population. Reporting systems were the Israel Cancer Registry, the medical documentation of all-Kaposi's sarcoma cases and the registry of HIV-seropositive patients. Patients who were seropositive for HIV were excluded from the study population. Population figures for groups of migrants and natives were derived from census surveys (1961, 1972, 1983) and inter-census estimates based on the population registry.
The overall age-standardized rate of CKS was 16.9 per million in men and 6.3 per million in women. The ratio between genders remained stable during the study period. In both genders, there was a steep increase in CKS incidence between the late 1960s (age-standardized rates per million: 8.0 in men and 2.2 in women) and the early 1970s (17.9 in men and 6.7 in women). No further increase was present after 1971. Overall, immigrants experienced a relative risk (RR) of 1.17 [95% confidence interval (CI) 0.90-1.521 compared with Jews born in Israel. Immigrants from Morocco, Algeria and Tunisia had the highest incidence (RR 2.01; 95% CI 1.52-2.65) compared with Jews born in Israel, followed by those born in Iraq (RR 1.74; CI 95% 1.27-2.37). The lowest incidence was experienced by immigrants from Iran (RR 0.37; CI 95% 0.18-0.77) and from Central European countries (RR 0.45; CI 95% 0.30-0.66). Immigrants from other countries in Asia, Africa, the Americas and Europe had similar rates as Jews born in Israel.
Israeli Jews present one of the highest incidences of CKS reported from developed countries. The incidence varies according to geographical origin. Countries surrounding the Mediterranean sea represent the area of highest CKS incidence.
据报道,经典型卡波西肉瘤(CKS)在大多出生于东欧的犹太人群中发病率较高。
描述以色列犹太人中CKS的发病率,并根据其地理来源确定发病率的差异。
我们分析了1961年至1989年间在以色列犹太人群中发生的1098例已知原籍国的CKS新发病例的数据。报告系统包括以色列癌症登记处、所有卡波西肉瘤病例的医疗记录以及HIV血清阳性患者登记处。HIV血清阳性患者被排除在研究人群之外。移民群体和本地人的人口数据来自人口普查(1961年、1972年、1983年)以及基于人口登记处的普查间估计。
CKS的总体年龄标准化发病率男性为每百万16.9例,女性为每百万6.3例。在研究期间,性别比例保持稳定。在男女两性中,20世纪60年代末(每百万年龄标准化发病率:男性8.0例,女性2.2例)至70年代初(男性17.9例,女性6.7例)CKS发病率急剧上升。1971年后未再出现进一步上升。总体而言,与出生在以色列的犹太人相比,移民的相对风险(RR)为1.17[95%置信区间(CI)0.90 - 1.52]。与出生在以色列的犹太人相比,来自摩洛哥、阿尔及利亚和突尼斯的移民发病率最高(RR 2.01;95% CI 1.52 - 2.65),其次是出生在伊拉克的移民(RR 1.74;95% CI 1.27 - 2.37)。来自伊朗的移民(RR 0.37;95% CI 0.18 - 0.77)和中欧国家的移民(RR 0.45;95% CI 0.30 - 0.66)发病率最低。来自亚洲、非洲、美洲和欧洲其他国家的移民发病率与出生在以色列的犹太人相似。
以色列犹太人呈现出发达国家报告的CKS最高发病率之一。发病率因地理来源而异。地中海周边国家是CKS发病率最高的地区。